4 New Unicorns in August 2025

August 2025 proved to be another interesting month in the ever-volatile world of venture capital, but for the minting of unicorns, it was pretty slow going. However, despite tighter funding conditions globally, four companies – spanning artificial intelligence, biotech, design software and logistics optimisation – crossed the billion-dollar valuation mark, earning the coveted “unicorn” status. Their ascent is as much a story about their individual breakthroughs as it is about the broader shifts reshaping capital flows and innovation hotspots.

The new entrants are Field AI, Kriya Therapeutics, Framer and Decart – each emblematic of a sector at the sharp edge of disruption. Together, they offer a snapshot of how investors are positioning themselves for the next decade – that is,  betting on technology that doesn’t just serve today’s markets, but redefines tomorrow’s.

 

Why Only Four? A Funding Climate Still Under Pressure

 

The fact that just four companies joined the unicorn club in August speaks volumes about the funding climate. Global venture capital activity remains muted, with investors more cautious, valuations under closer scrutiny and capital flowing selectively into sectors deemed essential rather than aspirational.

Rising interest rates in major economies have made cheap money a relic of the past, and limited partners are pressing funds for returns rather than new bets. This environment is forcing investors to distinguish more sharply between promising experiments and companies with the potential to achieve real-world scale.

The result has been a dramatic slowdown in unicorn creation. Compared with the heady days when double-digit unicorns could appear in a single month, August’s four underline the new reality – unfortunately, billion-dollar valuations are no longer handed out with abandon. They’re hard-earned.

 

Where the Money Flows: Signals from August’s Cohort

 

If the low number of unicorns tells us about the funding environment, the sectors they represent tell us about investor priorities. August’s cohort spans four industries – artificial intelligence, biotech, design software and logistics optimisation, each reflecting areas where disruption is already colliding with necessity.

Now, this pattern isn’t accidental. Investors are funnelling capital towards companies that tackle structural challenges – how to make industries more efficient (Field AI), how to treat diseases with no existing therapies (Kriya Therapeutics), how to equip the digital workforce with sharper tools (Framer) and how to optimise supply chains in an unstable global economy (Decart).

These themes suggest a recalibration of what it means to be investable in 2025. Unicorns are emerging not in speculative consumer plays, but in spaces where technology and market demand intersect with pressing global needs. It’s a signal that the next decade’s defining companies may look very different from those that came before.

 

 

The 4 Newest Unicorns Minted in August 2025

 

So, in a world in which achieving a billion-dollar valuation for privately-owned companies has become pretty challenging, especially in the current economic environment, here are the four businesses that became unicorns in August 2025.

 

Field AI: $2 Billion

 

 

Field AI is a robotics software company founded in 2023 by Ali Agha, headquartered in Mission Viejo, California. According to industry reports, its core offering is a “universal, risk-aware brain” for mobile robots (called Field Foundation Models) that enables robots across construction, logistics, energy and infrastructure to operate safely in real-world environments without relying on fixed maps or GPS.

What makes Field AI unique is its hardware-agnostic autonomy stack – indeed, rather than building for a single robot type, it develops intelligence adaptable to many. This has strong appeal for industries with high safety and reliability demands.

Field AI’s rapid ascent to unicorn status, now valued at around US$2 billion, was fuelled by a major $314 million funding round in August 2025 with backing from prominent investors including Bezos Expeditions and Temasek.

 

Kriya Therapeutics: $1.7 Billion

 

Kriya was founded in late 2019 by Shankar Ramaswamy, Roger Jeffs and John Fraser Wright. The company is a next-generation gene therapy biotech, focused not only on rare genetic disorders but also on prevalent chronic conditions such as diabetes, obesity and liver disease.

According to biotech analysts, Kriya stands out because of its fully integrated platform: advanced gene editing, proprietary computational tools and in-house manufacturing. This combination reduces costs and shortens development timelines, tackling one of the industry’s biggest bottlenecks.

Its leadership team brings proven expertise from some of the most successful gene therapy ventures of the past decade. Investors believe the company could make gene therapies scalable beyond niche diseases, a vision that helped it secure substantial Series C funding in August 2025. That round lifted Kriya’s valuation to roughly US$1.7 billion, officially cementing its unicorn status.

 

Framer: $2 Billion

 

 

 

Framer is a no-code design and web-building platform, founded in Amsterdam in 2014 by Koen Bok and Jorn van Dijk. It began life as an interactive prototyping tool for designers, before evolving into a full website creation platform. Today, it enables teams to build, publish and test sites with no engineering overhead, while offering advanced features like SEO optimisation, analytics and A/B testing.

According to startup media, Framer has grown to support hundreds of thousands of active sites and a million monthly users, becoming a favourite among both fast-growth startups and established global brands. Its appeal lies in narrowing the gap between design and development – allowing non-technical teams to move at speed without compromising on flexibility or quality.

In August 2025, Framer raised nearly $100 million in Series D funding, valuing the company at about US$2 billion and pushing it into unicorn territory.

 

Decart: $3.1 Billion

 

 

Decart is an Israeli AI company founded in 2023 by Dean Leitersdorf and Moshe Shalev. The company focuses on dramatically lowering the cost of training and running large AI models, while also pioneering creative AI applications in video generation. According to venture capital reports, Decart’s technology delivers significant GPU efficiency gains, making advanced AI infrastructure more affordable for enterprises.

The company has also launched products such as Oasis and Mirage, which enable high-quality, real-time video content generation, attracting strong demand from media and marketing industries.

What differentiates Decart is its dual play: selling infrastructure solutions that cut costs for AI developers, while simultaneously generating consumer-facing creative tools. This early diversification helped the company achieve revenues quickly, unusual for a young AI lab. In August 2025, Decart closed a $100 million Series B round, propelling its valuation to approximately US$3.1 billion.